A multi-institutional team of researchers at the University of Toronto has unveiled a next-generation RNA therapeutic platform designed to target…
Read More
Unlocking the Hidden Architecture of Blood Cancers: How Bone Marrow Inflammation Fuels Pre-Leukemic States and Aging
Every single second, the human bone marrow functions as a biological factory of astonishing scale, generating millions of fresh blood…
Read More
New Therapies Usher in Era of Personalised Treatment for Rare Blood Cancers
A significant advancement in the treatment of rare blood cancers is set to transform the lives of approximately 200 patients…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.
A collaborative study conducted by researchers at the University of Michigan and the University of California San Diego has identified…
Read More
Calderasib’s Real Innovation: Designed for Combinability and Potency Unlocks New Frontiers in KRAS-Mutated Cancers
Merck’s latest investigational drug, calderasib, is not merely another entry into the burgeoning field of KRAS G12C inhibition; it represents…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels
The persistence of estrogen receptor-positive (ER+) breast cancer remains one of the most formidable challenges in modern oncology, as patients…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.
This seminal research, conducted by a collaborative team from the University of Michigan and the University of California San Diego,…
Read More
Why tumors resist immunotherapy: how removing their armor can turn cold cancers hot
A groundbreaking study conducted by researchers at the University of California San Diego (CA, USA) has pinpointed microRNA-25 (miR-25) as…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels.
A collaborative research effort between the University of Michigan and the University of California San Diego has identified a critical…
Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnels
In a breakthrough study published in the Journal of Clinical Investigation, researchers from the University of Michigan and the University…
Read More
